Correlation Between Monopar Therapeutics and Mundus
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and Mundus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and Mundus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and Mundus Group, you can compare the effects of market volatilities on Monopar Therapeutics and Mundus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Mundus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Mundus.
Diversification Opportunities for Monopar Therapeutics and Mundus
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Monopar and Mundus is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Mundus Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mundus Group and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Mundus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mundus Group has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Mundus go up and down completely randomly.
Pair Corralation between Monopar Therapeutics and Mundus
Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 1.66 times more return on investment than Mundus. However, Monopar Therapeutics is 1.66 times more volatile than Mundus Group. It trades about 0.39 of its potential returns per unit of risk. Mundus Group is currently generating about 0.03 per unit of risk. If you would invest 2,298 in Monopar Therapeutics on November 4, 2024 and sell it today you would earn a total of 2,096 from holding Monopar Therapeutics or generate 91.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 90.91% |
| Values | Daily Returns |
Monopar Therapeutics vs. Mundus Group
Performance |
| Timeline |
| Monopar Therapeutics |
| Mundus Group |
Monopar Therapeutics and Mundus Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monopar Therapeutics and Mundus
The main advantage of trading using opposite Monopar Therapeutics and Mundus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Mundus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mundus will offset losses from the drop in Mundus' long position.| Monopar Therapeutics vs. Anebulo Pharmaceuticals | Monopar Therapeutics vs. Acrivon Therapeutics, Common | Monopar Therapeutics vs. Pmv Pharmaceuticals | Monopar Therapeutics vs. Molecular Partners AG |
| Mundus vs. Absolute Health and | Mundus vs. Supurva Healthcare Group | Mundus vs. Alpha Wastewater | Mundus vs. CTR Investments Consulting |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |